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Abstract
Background: We had found a 14% higher incidence of pneumonia with vitamin E supplementation
in a subgroup of the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study cohort:
participants who had initiated smoking by the age of 20 years. In this study, we explored the
modification of vitamin E effect by body weight, because the same dose could lead to a greater
effect in participants with low body weight.
Methods: The ATBC Study recruited males aged 50–69 years who smoked at least 5 cigarettes
per day at the baseline; it was conducted in southwestern Finland in 1985–1993. The current study
was restricted to 21,657 ATBC Study participants who initiated smoking by the age of 20 years; the
median follow-up time was 6.0 years. The hospital-diagnosed pneumonia cases were retrieved from
the national hospital discharge register (701 cases).
Results: Vitamin E supplementation had no effect on the risk of pneumonia in participants with
body weight in a range from 70 to 89 kg (n = 12,495), risk ratio (RR) = 0.99 (95% CI: 0.81 to 1.22).
Vitamin E increased the risk of pneumonia in participants with body weight less than 60 kg (n =
1054), RR = 1.61 (1.03 to 2.53), and in participants with body weight over 100 kg (n = 1328), RR
= 2.34 (1.07 to 5.08). The harm of vitamin E supplementation was restricted to participants with
dietary vitamin C intake above the median.
Conclusion: Vitamin E supplementation may cause harmful effects on health in certain groups of
male smokers. The dose of vitamin E used in the ATBC Study, 50 mg/day, is substantially smaller
than conventional vitamin E doses that are considered safe. Our findings should increase caution
towards taking vitamin E supplements.
Trial registration: ClinicalTrials.gov NCT00342992.
Background
According to a recent survey, about half of 60 years and
older US adults took supplements containing vitamin E,
and half of them took high doses, ≥ 400 IU/day [1]. Such
a common habit makes the health effects of this practice
an important public health issue and raises the question
of whether taking vitamin E supplements is beneficial or
not.
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The rationale behind vitamin E supplementation is based
on the protection against oxidative stress, which has a role
in diverse aging processes [2,3]. However, in randomized
trials vitamin E supplementation has not reduced mortal-
ity implying that it has no substantial effect on the proc-
esses leading to chronic diseases [4-6].
Specifically, vitamin E supplementation has been advo-
cated for improving the immune system [7,8]. A number
of animal studies found that vitamin E reduced the inci-
dence and severity of various viral and bacterial infections
[9]. On the other hand, vitamin E shortened the survival
of mice with malaria [10,11] and increased the multipli-
cation of Leishmania parasites in hamsters [12]. Two stud-
ies in human subjects found that large doses of vitamin E
depressed bactericidal activity of phagocytes [13,14].
Thus, vitamin E supplementation can also be harmful to
the immune system.
Vitamin E is a major lipid soluble anti-oxidant whereas
vitamin C is a major water-soluble antioxidant. They
interact in vitro and in vivo [9,15-17]. Smoking increases
the plasma α-tocopherol disappearance rate, which is nor-
malized by vitamin C supplementation [17]. Thus, smok-
ing seems to modify the interaction between these two
antioxidants. Therefore, vitamin C is particularly impor-
tant when examining the effects of vitamin E supplemen-
tation on smokers.
Previously we analyzed the Alpha-Tocopherol Beta-Caro-
tene Cancer Prevention (ATBC) Study cohort and found
significant heterogeneity in the effect of vitamin E supple-
mentation on the incidence of the common cold, pneu-
monia and tuberculosis [18-20]. Vitamin E reduced
pneumonia risk by 35% in 7,469 participants who initi-
ated smoking at 21 years or later, but in those who initi-
ated smoking earlier the vitamin elevated pneumonia risk
nonsignificantly by 14% [18]. Furthermore, the subgroup
of participants who initiated smoking late was so large (n
= 7,469) that we carried out second-level subgroup analy-
ses and found significant heterogeneity in the effect of
vitamin E supplementation by the level of smoking [18].
The group of participants who initiated smoking at early
age is even larger (n = 21,657) and therefore further sub-
group analysis is justified to examine whether there is het-
erogeneity in vitamin E effect also in this subgroup.
The ATBC Study was a randomised, double-blind, pla-
cebo-controlled trial which examined the effects of vita-
min E and β-carotene on lung cancer in male smokers
using a 2 × 2 factorial design [21,22]. A single dose of vita-
min E, 50 mg/day (50 IU/day), was used and therefore the
dose-response of vitamin E supplementation cannot be
examined directly. Nevertheless, the dose-response can be
explored indirectly by examining the variation of vitamin
E effect by body weight. Thus, we anticipated a greater
effect on those who had the lowest body weight.
The primary objective of this study was to examine
whether body weight modifies the increased pneumonia
risk by vitamin E supplementation in the 21,657 ATBC
Study participants who had initiated smoking at an early
age [18]. As a secondary objective we explored whether
dietary vitamin C intake and other major baseline varia-
bles might modify the effect of vitamin E supplementa-
tion.
Methods
Participants
The design and methods of the ATBC Study examining the
effects of vitamin E (dl-α-tocopheryl acetate, AT, 50 mg/
day) and β-carotene (BC, 20 mg/day) on the incidence of
lung cancer and other cancers have been described in
detail [18,21,22]. The ATBC Study is registered at Clinical-
Trials.gov under the identifier NCT00342992.
In brief, to be eligible, male participants aged 50–69 years
had to smoke ≥ 5 cigarettes per day at entry, and those
enrolled in the trial (N = 29,133) were randomised to one
of four intervention arms and administered placebo, AT,
BC, or AT+BC, using a 2 × 2 factorial design. Compared
with the baseline levels, supplementation increased the
serum level of α-tocopherol by 50% [22]. The interven-
tion continued for 5 to 8 years until April 1993. The trial
was approved by the institutional review boards and all
participants gave written informed consent. We restricted
the present analysis to participants who started to smoke
at ≤ 20 years (N = 21,657), with 10,784 participants who
were administered vitamin E (AT and AT+BC) and 10,873
participants who were not administered vitamin E (pla-
cebo and BC).
Baseline characteristics
Before randomisation at baseline, the men completed
questionnaires on medical and smoking histories and
general background characteristics, and height and weight
were measured. A detailed dietary history questionnaire
was completed that provided data regarding vitamin C,
vitamin E, fruit, vegetable, and berry consumption [23].
Body-mass-index (BMI) was calculated as weight/height2
[kg/m2]. Dietary data were not available for 1463 of the
21,657 participants. Weight was not available for 12,
height for 11 and BMI for 14 participants.
Outcome and follow-up time
The events for this study, the first hospital-treated pneu-
monia after randomization, were ascertained from the
national Hospital Discharge Register using the unique
personal identification number for linkage (see details in
Ref. [18]). Pneumonia cases recorded in the Hospital Dis-Nutrition Journal 2008, 7:33 http://www.nutritionj.com/content/7/1/33
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charge Register reflect clinically more severe cases of
greater health and economic significance, whereas less
severe cases of pneumonia treated as outpatients are not
recorded in the Register. Because almost all of the ATBC
Study participants lived at home, the pneumonia cases
ascertained represent community-acquired pneumonia;
medical records were not reviewed to rule out the few
nosocomial infections.
Statistical methods
Follow-up time for each participant began from the day of
randomization, and continued until the date of first hos-
pital discharge for pneumonia, death, or the end of the
trial, April 30, 1993, whichever came first. In cases where
both pneumonia and lung cancer were present in the
same discharge record (n = 57 cases), follow-up was cen-
sored at the date of hospital discharge, but the participant
was not classified as a case of pneumonia, as previously
[18].
The median follow-up time of the participants in the
present analysis was 6.0 years, and there was a total of
124,612 person-years of observation. Use of the Hospital
Discharge Register allowed obtaining information on
pneumonia in study participants irrespective of whether
they continued in or had dropped out from the trial.
We estimated the effect of vitamin E supplementation on
pneumonia incidence through proportional hazards
regression models. We calculated the risk ratio (RR) and
the 95% confidence interval (CI) of the RR using the
PROC PHREG program of the SAS package of programs
(release 8.2, SAS Institute, Inc., Cary, North Carolina). The
2 × 2 factorial design of the trial permitted assessment of
the effect of vitamin E independent of β-carotene after
confirming no statistical interaction between the agents.
Thus, we compared the trial participants administered
vitamin E (AT and AT+BC) with those not receiving vita-
min E (the no-vitamin E group; placebo and BC). We did
not analyze the effects of β-carotene in this study. As to
supplementation, we carried out the analyses following
the intention-to-treat principle. When appropriate, we
adjusted the statistical models for age, baseline smoking,
intake of coffee and BMI as continuous variables, and for
the intake of alcohol categorized to 0, > 0–29, 30–59, and
≥ 60 g/day, and being employed categorized to yes/no
[18].
To test the statistical significance of interaction between
vitamin E supplementation and potential modifying fac-
tors, we first added the supplementation and the modify-
ing factor to the regression model. The statistical
significance of the interaction was thereafter calculated
from the change in -2 × log(likelihood) when the interac-
tion term for vitamin E supplementation and the modify-
ing factor was added to the model. In our subgroup
analyses to assess effect modification, we split at the
median the BMI, height, dietary vitamin E and C levels,
and the residual of fruit, vegetables, and berries (see
below). Dietary vitamin C was also used as a continuous
variable since interaction with a continuous variable
refutes the possibility that dichotomizing a continuous
variable may cause a spurious interaction; to decrease the
weight of distant points, the logarithm of dietary vitamin
C intake was included in the statistical model.
The major vitamin C sources in the diet of the study par-
ticipants were fruit, vegetables and berries; on average
58% of dietary vitamin C originated from these foods. The
total intake of fruit, vegetables and berries (FRUVEBE)
was strongly correlated with the calculated vitamin C
intake (r = 0.88). Thus, it is possible that an association
with dietary vitamin C is a statistical artefact reflecting
other substances of these foods or the life style related to
eating these foods. To examine the possible role of dietary
compounds other than vitamin C in these foods, we cal-
culated the residual of FRUVEBE intake (FBUVEBE-RES)
using linear regression to model FRUVEBE as a function of
dietary vitamin C, as previously [24]:
FBUVEBE-RES [g/day] = FRUVEBE [g/day] - 2.47 × vita-
min C [mg/day] + 36.3 [g/day]
As designed, FRUVEBE-RES had no correlation with die-
tary vitamin C. We assume that any other putative com-
pounds that might interact with vitamin E
supplementation have no perfect linear correlation with
vitamin C and therefore variation in the other substances
remains as variation in FRUVEBE-RES. High FRUVEBE-
RES (over median) indicates that the participant with a
given vitamin C level consumes more than the average
amount of fruit, vegetables and berries, whereas low FRU-
VEBE-RES (below median) indicates less than the average
intake of these food classes.
Nelson-Aalen cumulative hazard functions were con-
structed using STATA sts program (Release 9, Stata Corp,
College Station, TX). Two-tailed P-values were used.
Results
Table 1 shows the distribution of the major characteristics
of the ATBC Study participants who initiated smoking by
the age of 20 years. During 124,612 person-years of fol-
low-up, there were 701 new cases of hospital-treated
pneumonia, representing a mean incidence rate of 5.6
cases per 1000 person-years.
Overall, the risk of pneumonia was nonsignificantly 14%
higher in the vitamin E-supplemented participants com-
pared with the no-vitamin E participants (Table 2). Vita-Nutrition Journal 2008, 7:33 http://www.nutritionj.com/content/7/1/33
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min E had no effect, RR = 0.99, on those with body weight
in the middle range from 70 to 89 kg, which covers the
great majority of this cohort. In participants with the low-
est and highest body weight, vitamin E supplementation
significantly increased the risk of pneumonia (Table 2). In
the groups next to the extremes, there was a nonsignificant
elevation of pneumonia risk by vitamin E supplementa-
tion suggesting a trend. Our further explorative subgroup
Table 1: Baseline characteristics of ATBC Study participants initiating smoking at ≤ 20 years
Characteristic Number of participants
All participants 21657
Age (years)
50–54 7778
55–59 6908
60–64 5058
65–69 1913
Cigarettes per day at baseline
5–19 7295
20–29 10259
≥ 30 4103
BMI (kg/m2) *
≤ 19 700
20–24 7781
25–29 9902
≥ 30 3260
Education (years at school)
≤ 6 17253
7–9 2956
≥ 10 1448
Residential neighborhood during the last 20 years *
City (> 50,000 inhab.) 9305
Town 4667
Village 3160
Countryside 4519
* BMI was missing for 14 and residential neighborhood for 6 participants.
Table 2: Relative risk of hospital-treated pneumonia by vitamin E supplementation in participants initiating smoking at ≤ 20 years, 
ATBC Study 1985–1993
Intervention Effect of vitamin E
Vitamin E No vitamin E
Subgroup No. of participants No. of cases Rate* No. of cases Rate* RR (95% CI)*
All 21657 370 6.0 331 5.3 1.14 (0.98–1.32)
Weight (kg) †
36–59 1054 47 16.7 32 10.4 1.61 (1.03–2.53)
60–69 4115 79 6.7 68 5.7 1.17 (0.84–1.62)
70–89 12495 182 5.1 187 5.1 0.99 (0.81–1.22)
90–99 2653 39 5.2 34 4.5 1.17 (0.74–1.86)
100–154 1328 22 5.7 9 2.5 2.34 (1.07–5.08)
β-Carotene
No 10842 204 6.6 169 5.4 1.22 (0.99–1.50)
Yes 10815 166 5.4 162 5.2 1.04 (0.84–1.30)
* Rate is given as the number of pneumonia cases per 1,000 person-years. Risk ratio (RR) was estimated using the proportional hazards regression 
model comparing participants who received vitamin E and those who did not. No covariates were included in the models, because the comparison 
is between large randomized groups. The sizes of the compared intervention groups are the same within 10% accuracy in the lowest and highest 
body-weight groups, and within 2% in the other comparisons. The uniformity of the vitamin E effect was tested by adding a dummy variable for 
vitamin E effect in the 36–59, 60–69, 90–99 and 100–154 kg groups, allowing each of the four groups their own vitamin E supplementation effect. 
The regression model was improved by χ2(4 df) = 7.76, P = 0.10, compared to the model with a uniform vitamin E effect. Adding the vitamin E 
effect only in the 36–59 and 100–154 kg groups improved the model by χ2(2 df) = 6.79, P = 0.034, compared to the model with a uniform vitamin E 
effect.
† Weight was missing for 12 participants; two of them had pneumonia, one in the vitamin E group and one in the no-vitamin E group.Nutrition Journal 2008, 7:33 http://www.nutritionj.com/content/7/1/33
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analyses were focused on the lowest and highest body-
weight subgroups (Tables 3 and 4). Restriction to smaller
subgroups may lead to unbalance in potential confound-
ers, and therefore we adjusted regression models in Tables
3 and 4 with potential confounders. These tables are
restricted to participants for whom the confounders were
available.
In the lowest body-weight participants, the effect of vita-
min E supplementation was not modified by BMI, a meas-
ure of relative weight (Table 3). In the highest body-
weight participants, the harm of vitamin E was more evi-
dent in those who had high BMI, but the interaction was
not statistically significant (Table 4). Height did not mod-
ify the effect of vitamin E supplementation in these sub-
groups.
Dietary vitamin E intake did not significantly modify the
effect of vitamin E supplementation in the low and high
weight subgroups. Still, the harm of supplementation was
more evident in the low body-weight participants who
had high dietary vitamin E intake (Table 3).
Dietary vitamin C intake significantly modified the effect
of vitamin E supplementation in both low and high body-
weight participants, so that the harm from supplementa-
tion was restricted to those with dietary vitamin C intake
over the median of the body-weight group (Tables 3 and
4). In the low body-weight group, the interaction between
vitamin E supplementation and the dietary vitamin C
intake as a continuous variable was significant (P =
0.018), but not in the high body-weight group (P = 0.3).
Figure 1 shows the survival curves for vitamin E and no-
vitamin E participants in the low and high body-weight
groups with dietary vitamin C intake over the median. In
both groups, the difference between the vitamin E and no-
vitamin E groups was highly significant in the logrank test
(P = 0.002). In the low body-weight group, the survival
curves diverged immediately after the initiation of supple-
mentation (Fig. 1A). However, in the high body-weight
group there is a lag period of 1.5 years before cases of
pneumonia started to occur in the vitamin E participants
(Fig. 1B).
The main food sources for vitamin C are fruit, vegetables
and berries and therefore we tested whether some other
substances in these foods might explain the effect modifi-
cation by vitamin C. We modelled fruit, vegetable and
berry intake with dietary vitamin C as the explanatory var-
iable, and calculated the residual intake of fruit, vegeta-
bles and berries. The residual had no significant
association with vitamin E supplementation effect (Tables
Table 3: Lightest participants (body-weight < 60 kg) initiating smoking at ≤ 20 years: relative risk of hospital-treated pneumonia by 
vitamin E supplementation
Intervention Effect of vitamin E
Vitamin E No vitamin E
Subgroup No. of participants No. of cases No. of cases RR (95% CI)* P-value for interaction
All 935 41 25 1.84 (1.11–3.0)
BMI †
< median 467 25 17 1.87 (0.99–3.5) 0.8
≥ median 468 16 8 2.12 (0.90–5.0)
Height †
< median 461 16 10 1.91 (0.85–4.3) 0.9
≥ median 474 25 15 1.86 (0.97–3.6)
Dietary vitamin E †
< median 467 15 15 1.30 (0.63–2.7) 0.2
≥ median 468 26 10 2.70 (1.30–5.6)
Dietary vitamin C †
< median 467 15 16 0.98 (0.48–2.0) 0.026
≥ median 468 26 9 3.48 (1.61–7.5)
Residual of fruit, vegetables, berries †
< median 467 19 15 1.53 (0.76–3.1) 0.6
≥ median 468 22 10 2.27 (1.06–4.9)
β-Carotene supplementation
No 476 23 12 2.20 (1.06–4.5) 0.7
Yes 459 18 13 1.62 (0.78–3.4)
* Proportional hazards regression model comparing participants who received vitamin E with those who did not. The regression models were 
adjusted for age, baseline smoking, intake of coffee and alcohol, BMI and employment. Participants with missing data on confounders (n = 119) are 
excluded from this table. The sizes of all compared intervention groups are the same within 25% accuracy. RR, risk ratio; CI, confidence interval.
† The medians for the light-weight group are: weight 57.0 kg; BMI 20.0 kg/m2; height 168 cm; dietary vitamin E intake 9.1 mg/day; dietary vitamin C 
intake 75.3 mg/day; residual of fruit, vegetable, and berry intake -2.9 g/day.Nutrition Journal 2008, 7:33 http://www.nutritionj.com/content/7/1/33
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3 and 4), indicating that other substances in these foods
do not explain the modification by dietary vitamin C.
Level of smoking at baseline and leisure time exercise did
not significantly modify the effect of vitamin E supple-
mentation in the low or high body-weight subgroups
(data not shown).
In participants with body weight in the middle range from
70 to 89 kg, the effect of vitamin E supplementation was
not significantly modified by the baseline variables we
tested for the lowest and highest body-weight groups
(data not shown).
Discussion
In this study we surmised that the non-significant increase
in pneumonia risk by vitamin E supplementation in the
large study cohort might camouflage a greater effect in
participants with low body weight because the dose per
weight is greater for them. Consistent with our expecta-
tion, we found a significant effect by vitamin E supple-
mentation on participants with the lowest body weight,
whereas vitamin E had no effect on participants in the
middle range of body weight (Table 2). The harm of vita-
min E supplementation was restricted to low-weight par-
ticipants with high dietary vitamin C intake (Table 3, Fig.
1A).
We also observed increased pneumonia risk by vitamin E
supplementation in participants with the highest body
weight (Table 2). This finding was unexpected and is not
consistent with our rationalization for the subgroup anal-
ysis by body weight. It is possible that obesity makes peo-
ple more sensitive to the potential harms of vitamin E.
Although our subgroup selection was based on body
weight and not BMI, the heaviest-weight participants had
a high median BMI of 33.5 kg/m2 and, furthermore, the
harm was more pronounced in participants with BMI over
the median. In this subgroup, the harm of vitamin E sup-
plementation was also restricted to participants with die-
tary vitamin C intake above the median (Table 4, Fig. 1B).
In the heavy weight participants with high dietary vitamin
C intake, there was a lag period of 1.5 years before cases of
pneumonia started to occur in the vitamin E group (Fig.
1B). Vitamin E is a fat soluble antioxidant and it is accu-
mulated in the adipose tissue. In a one-year pharmacoki-
netic study, high dose α-tocopherol supplementation
increased the ratio of α-tocopherol to γ-tocopherol in the
adipose tissue continuously over the study [25], and in a
three-month study, high dose α-alpha-tocopherol
increased buccal mucosa cell vitamin E levels over the
study [26], indicating that α-tocopherol accumulation in
the adipose tissue is a process of months or years. Accord-
ingly, the lag period in our high weight participants may
Table 4: Heaviest participants (body-weight ≥ 100 kg) initiating smoking at ≤ 20 years: relative risk of hospital-treated pneumonia by 
vitamin E supplementation
Intervention Effect of vitamin E
Vitamin E No vitamin E
Subgroup No. of participants No. of cases No. of cases RR (95% CI)* P-value for interaction
All 1226 20 7 3.10 (1.30–7.4)
BMI †
< median 613 8 4 2.18 (0.64–7.4) 0.3
≥ median 613 12 3 4.66 (1.30–16.7)
Height †
< median 593 11 5 2.19 (0.75–6.3) 0.4
≥ median 633 9 2 5.50 (1.11–27.1)
Dietary vitamin E †
< median 613 11 4 3.00 (0.94–9.5) 0.9
≥ median 613 9 3 3.85 (0.93–15.9)
Dietary vitamin C †
< median 613 8 6 1.37 (0.46–4.0) 0.019
≥ median 613 12 1 14.5 (1.84–114.5)
Residual of fruit, vegetables, berries †
< median 613 12 4 3.55 (1.13–11.2) 0.8
≥ median 613 8 3 2.65 (0.69–10.1)
β-Carotene supplementation
No 622 10 3 3.23 (0.89–11.8) 0.9
Yes 604 10 4 3.90 (1.10–13.8)
* Proportional hazards regression model comparing participants who received vitamin E with those who did not. The regression models were 
adjusted for age, baseline smoking, intake of coffee and alcohol, BMI and employment. Participants with missing data on confounders (n = 102) are 
excluded from this table. The sizes of all compared intervention groups are the same within 15% accuracy. RR, risk ratio; CI, confidence interval.
† The medians for the high-weight group are: weight 106.0 kg; BMI 33.5 kg/m2; height 179 cm; dietary vitamin E intake 12.4 mg/day; dietary vitamin 
C intake 95.5 mg/day; residual of fruit, vegetable, and berry intake -4.8 g/day.Nutrition Journal 2008, 7:33 http://www.nutritionj.com/content/7/1/33
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be explained by slow accumulation of vitamin E in the
adipose tissue before the adverse effects start to appear
(Fig. 1B).
We assumed that vitamin E supplementation might be
more harmful for participants with high dietary vitamin E
intake because supplementation could lead to higher sys-
temic levels compared with participants with low dietary
vitamin E intakes. In the low body-weight participants we
saw a tendency in the expected direction, yet the interac-
tion between dietary and supplemented vitamin E was not
statistically significant (Table 3).
Given the proposal that vitamin E supplementation
would improve the immune system of elderly people
[7,8], our results are alarming. We do not have a biochem-
ical explanation for our findings indicating that vitamin E
may increase pneumonia risk in some population groups.
Nevertheless, previous reports have indicated that vitamin
E may have harmful effects on the immune system [10-
14].
In this study, we carried out several subgroup analyses,
which might lead to a few low P-values simply because of
the multiple comparison problem. However, at both ends
of the body-weight scale, the risk of pneumonia was mod-
ified by the same variable, namely dietary vitamin C
intake, and in both cases the harm was limited to the sub-
group with high dietary vitamin C. Furthermore, previ-
ously we found that vitamin E supplementation increased
the risk of tuberculosis in participants with high dietary
vitamin C intake [20], and in this respect the current find-
ings are consistent with the earlier. Furthermore, the P-
values testing the divergence between the vitamin E and
no-vitamin E groups in the identified subgroups are par-
ticularly small, P = 0.002 (Fig. 1), and based on reasona-
ble numbers of cases among several hundreds of
participants. On these grounds, the harm observed in the
identified subgroups probably is real and not explained
by multiple testing.
There is evidence indicating that vitamins E and C inter-
act, and based on biochemical studies, it was proposed
that high doses of vitamins C and E might be beneficial
for smokers because of the interaction [17]. Furthermore,
co-supplementation of high-dose vitamin C and vitamin
E is common [1]. We found an effect in the opposite direc-
tion so that vitamin E supplementation was harmful
Vitamin E supplementation and pneumonia risk in subgroups of the ATBC Study participants who started smoking at ≤ 20 years Figure 1
Vitamin E supplementation and pneumonia risk in subgroups of the ATBC Study participants who started 
smoking at ≤ 20 years. A) Weight < 60 kg and dietary vitamin C intake > 75 mg/day (n = 468). B) Weight ≥ 100 kg and die-
tary vitamin C intake > 95 mg/day (n = 613). Nelson-Aalen cumulative hazard functions for vitamin E and no-vitamin E groups 
are shown. Each step indicates one case of pneumonia. For the difference between the two survival curves, the logrank test 
gives A) P = 0.0021 and B) P = 0.0020. The survival curves are cut at 7.2 years because the number of participants declines 
abruptly thereafter. At 6-years of follow-up there were remaining 114 and 126 participants in A), and 146 and 162 participants 
in B), in the vitamin E and the no-vitamin E groups, respectively.
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when combined with high dietary vitamin C intake (Fig.
1). The vitamin E effect modification by dietary vitamin C
was not explained by other substances in fruit, vegetables,
and berries. We found a similar harmful interaction
between high dietary vitamin C and the effect of vitamin
E supplementation on tuberculosis risk [20]. Thus, our
findings should lead to caution against a combined high-
dose vitamin C and vitamin E supplementation, even
though the harm may be restricted to selected groups
among smokers.
The current US nutritional recommendations [27] and a
recent review [28] conclude that vitamin E is safe at levels
up to 1000 mg/day. However, our findings of the ATBC
Study indicate that some population groups may be
harmed even by a low dose of 50 mg/day (Fig. 1 and refs.
[19], [20]). In addition, a Dutch study with elderly people
found a significant increase in the severity of respiratory
infection by 200 mg/day of vitamin E [29]. Consequently,
in some population groups the upper limit of the safe
range may be substantially lower than the levels consid-
ered conventionally safe.
The two subgroups in which vitamin E increased the risk
of pneumonia risk, i.e., the lowest and highest body-
weight groups with high vitamin C intake, are small and
consist of only 5% of the participant population of the
current study (1081/21,657). If these two subgroups are
excluded from the study population, the point estimate
for the vitamin E supplementation effect on pneumonia
risk is reduced from +14% to +4.9%, which demonstrates
the restriction of the harm of vitamin E supplementation
to these two small subgroups. Nevertheless, the propor-
tion of participants harmed in these two small subgroups,
as measured by the increased occurrence of pneumonia, is
substantial. In the low body-weight participants with high
vitamin C intake, one out of every 13 participants got
pneumonia during the trial because of vitamin E supple-
mentation (the number needed to harm, NNH, is 13). In
the high body-weight participants with vitamin C intake
over the median, the NNH is 28.
There is evidence that vitamin E supplementation may
reduce the risk of the common cold and pneumonia in
restricted population groups which are so far poorly
defined [18,19,30]. However, the observed harms of 50 to
200 mg/day vitamin E supplementation in other popula-
tion groups indicate that vitamin E can also be detrimen-
tal to health. Vitamin E self-supplementation should be
discouraged until sub-populations that clearly benefit
from the supplementation are characterized properly.
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